| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | crizotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.035 | 0.3 |
| mRNA | TPCA-1 | GDSC1000 | pan-cancer | AAC | 0.028 | 0.3 |
| mRNA | BMS-754807 | CTRPv2 | pan-cancer | AAC | -0.035 | 0.3 |
| mRNA | BRD-K52037352 | CTRPv2 | pan-cancer | AAC | -0.04 | 0.3 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | -0.046 | 0.3 |
| mRNA | XL-184 | GDSC1000 | pan-cancer | AAC | -0.033 | 0.3 |
| mRNA | AZD-2281 | CTRPv2 | pan-cancer | AAC | -0.034 | 0.3 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | -0.045 | 0.3 |
| mRNA | BIRB 0796 | FIMM | pan-cancer | AAC | -0.2 | 0.3 |
| mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | 0.034 | 0.3 |